So from the 1970s when you first began your work as a young would-be surgeon, on ulcers to basically in 1993 and then the early 2000s when the GLP-1s were approved for use in diabetes, several decades have gone by, and then just in the, almost seems like with the flip of a switch, the drugs have changed the lives of tens of millions of people
While Mounjaros primary focus is diabetes treatment, its potential for weight management is promising
As the first FDA-approved oral GLP-1 receptor agonist , Rybelsus offers the convenience of a daily pill versus weekly injections like Ozempic or Wegovy, which justifies its premium positioning in the diabetes medication market
The anti-inflammatory mechanisms appear to be independent of weight loss or glycemic improvement, suggesting direct immunomodulatory properties
Its not like those awful pills
5: 53140 Lopez-Miranda J, Perez-Martinez P, Marin C, Moreno JA, Gomez P, Perez-Jimenez F